RECRUITMENT OPPORTUNITY: Senior Policy Advisor

An exciting opportunity has arisen within Volteface for an individual with solid experience of policy development and excellent communication skills.
In this key role, you will be responsible for Volteface’s policy analysis and development in a range of areas relevant to drug policy, with a particular focus on regulation.
You are responsible for the communication of Volteface’s policy positions to government and external stakeholders.
We are looking for someone with:
- Excellent policy analysis and writing skills, including speechwriting, writing briefings and developing policy from research and stakeholder engagement.
- The confidence to engage and build strong relationships with a wide range of stakeholders, including those at senior level.
- Excellent project management skills
- Works well both independently and as part of a team.
Job Description and Person Specification can be found here.
Role: Permanent, full time
Salary: £36,000 per year with annual increments
Location: 18 Hanway Street, London, W1T 1UF
Benefits for Volteface employees
Volteface offers attractive benefits including 25 days annual leave, flexible working, cycle to work scheme, generous contributions to a stakeholder pension scheme and training and development opportunities.
How to apply
Please send your CV and a cover letter to info@blunor.pk
Closing date: 30/09/2019
Interview date: tbc
About Volteface
Volteface is an advocacy organisation which seeks to reduce the harm drugs pose to individuals and society, through evidence-based policy and reform.
We cultivate fresh thinking and new ideas through our policy reports, online magazine and an ongoing programme of private and public events. We work with an array of partners across civil society, business, media and government to foster public engagement and formulate new evidence-based policy ideas. We are UK-based and focused whilst engaging with ideas and practice from across the world.
The week in drugs and drug policy, in one email.
The newsletter opens soon. Follow the RSS feed in the meantime.

